Clinical trial
Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic…
NCT00003427 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003427 |
|---|---|
| Title | Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer |
| Official title | Phase I Study to Evaluate the Combination Chemotherapy Regimen of Oxaliplatin Plus Irinotecan in Previously Treated Patients With Metastatic Gastrointestinal Cancer |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Anal Cancer, Colorectal Cancer, Esophageal Cancer, Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Gastric Cancer, Gastrointestinal Carcinoid Tumor, Liver Cancer, Pancreatic Cancer, Small Intestine Cancer |
| Intervention type | Drug |
| Interventions | irinotecan hydrochloride, oxaliplatin |
| Enrollment | 36 |
| Start date | Apr 1, 1998 |
| Primary completion | Apr 1, 2002 |
| Completion | Apr 1, 2002 |
| First posted | Apr 27, 2004 |
| Last update posted | Jun 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: